Diagnostic Accuracy of the HEART, SVEAT, and EDACS Scores for Predicting 30-Day Death or Percutaneous Coronary Intervention in Emergency Department Patients with Chest Pain

Background/Objectives: The HEART and EDACS scores are widely used to risk-stratify emergency department (ED) patients with chest pain, but direct comparison with the newer SVEAT score is limited. We compared all three scores in one cohort with a high event rate, each alone and combined with the same serial high-sensitivity troponin T (hs-cTnT) rule. Methods: In a retrospective secondary analysis of a prospectively collected registry at a Turkish tertiary care ED (April–August 2022), 1263 consecutive adults with non-traumatic chest pain were included. Three investigators who did not collect the outcome data calculated the HEART, EDACS and SVEAT scores from the clinical records. The outcome was 30-day all-cause death or percutaneous coronary intervention (PCI); myocardial infarction was not recorded as a separate outcome. Low risk was defined as HEART ≤ 3, SVEAT ≤ 4 and EDACS < 16; pathways added hs-cTnT < 14 ng/L at 0 h and 2 h. Results: The outcome occurred in 151 of 1263 patients (12.0%). HEART and SVEAT had similar discrimination (area under the curve [AUC] 0.845 versus 0.842; DeLong p = 0.824), and both exceeded standalone EDACS (0.735; both p < 0.001). Among patients classified as low risk by the score alone, the outcome occurred in 4.5% (HEART), 5.9% (SVEAT) and 7.4% (EDACS). With serial troponin, miss rates were 1.7%, 2.0% and 1.8%, respectively, and no significant difference in sensitivity was detected. Conclusions: In this high-prevalence cohort none of the scores alone reached an acceptable miss rate, and no pathway reached a 1% miss rate at the point estimate. The findings are from a single centre, are not externally validated and are subject to overlap between troponin and the outcome.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2026-11-17
DOI
https://doi.org/10.3390/diagnostics16223829
Primary Topic
Acute Myocardial Infarction Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diagnostic Accuracy of the HEART, SVEAT, and EDACS Scores for Predicting 30-Day Death or Percutaneous Coronary Intervention in Emergency Department Patients with Chest Pain

Haldun Akoğlu, Emir Ünal, Erhan Altunbaş, Mümin Murat Yazıcı et al.
2 links
Diagnostics
Acute Myocardial Infarction Research
article

Diagnostic Accuracy of the HEART, SVEAT, and EDACS Scores for Predicting 30-Day Death or Percutaneous Coronary Intervention in Emergency Department Patients with Chest Pain

Haldun Akoğlu, Emir Ünal, Erhan Altunbaş, Mümin Murat Yazıcı, Ali Çelik
article en

Abstract

Background/Objectives: The HEART and EDACS scores are widely used to risk-stratify emergency department (ED) patients with chest pain, but direct comparison with the newer SVEAT score is limited. We compared all three scores in one cohort with a high event rate, each alone and combined with the same serial high-sensitivity troponin T (hs-cTnT) rule. Methods: In a retrospective secondary analysis of a prospectively collected registry at a Turkish tertiary care ED (April–August 2022), 1263 consecutive adults with non-traumatic chest pain were included. Three investigators who did not collect the outcome data calculated the HEART, EDACS and SVEAT scores from the clinical records. The outcome was 30-day all-cause death or percutaneous coronary intervention (PCI); myocardial infarction was not recorded as a separate outcome. Low risk was defined as HEART ≤ 3, SVEAT ≤ 4 and EDACS < 16; pathways added hs-cTnT < 14 ng/L at 0 h and 2 h. Results: The outcome occurred in 151 of 1263 patients (12.0%). HEART and SVEAT had similar discrimination (area under the curve [AUC] 0.845 versus 0.842; DeLong p = 0.824), and both exceeded standalone EDACS (0.735; both p < 0.001). Among patients classified as low risk by the score alone, the outcome occurred in 4.5% (HEART), 5.9% (SVEAT) and 7.4% (EDACS). With serial troponin, miss rates were 1.7%, 2.0% and 1.8%, respectively, and no significant difference in sensitivity was detected. Conclusions: In this high-prevalence cohort none of the scores alone reached an acceptable miss rate, and no pathway reached a 1% miss rate at the point estimate. The findings are from a single centre, are not externally validated and are subject to overlap between troponin and the outcome.

DiagnosticsVol. 16(22)
Recep Tayyip Erdoğan University (TR), Marmara University (TR)
Good health and well-being
Acute Myocardial Infarction Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon